These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18667634)

  • 21. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107
    Khan AA; Srivastava R; Vahed H; Roy S; Walia SS; Kim GJ; Fouladi MA; Yamada T; Ly VT; Lam C; Lou A; Nguyen V; Boldbaatar U; Geertsema R; Fraser NW; BenMohamed L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of adjuvanting cancer vaccines with herpes simplex virus glycoprotein D on melanoma-driven CD8+ T cell exhaustion.
    Zhang Y; Ertl HC
    J Immunol; 2014 Aug; 193(4):1836-46. PubMed ID: 25024391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.
    Kim M; Osborne NR; Zeng W; Donaghy H; McKinnon K; Jackson DC; Cunningham AL
    J Immunol; 2012 May; 188(9):4158-70. PubMed ID: 22467654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.
    Koelle DM; Corey L; Burke RL; Eisenberg RJ; Cohen GH; Pichyangkura R; Triezenberg SJ
    J Virol; 1994 May; 68(5):2803-10. PubMed ID: 7512152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.
    Kuo T; Wang C; Badakhshan T; Chilukuri S; BenMohamed L
    Vaccine; 2014 Nov; 32(50):6733-45. PubMed ID: 25446827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects.
    Pajot A; Michel ML; Mancini-Bourgine M; Ungeheuer MN; Ojcius DM; Deng Q; Lemonnier FA; Lone YC
    Microbes Infect; 2006 Oct; 8(12-13):2783-90. PubMed ID: 17045504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1.
    Krüger S; Schroers R; Rooney CM; Gahn B; Chen SY
    J Immunother; 2003; 26(3):212-21. PubMed ID: 12806275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown.
    Chentoufi AA; Kritzer E; Yu DM; Nesburn AB; Benmohamed L
    Clin Dev Immunol; 2012; 2012():187585. PubMed ID: 22548113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of contiguous allele-specific peptide elements in the rubella virus E1 envelope protein.
    Nepom GT; Domeier ME; Ou D; Kovats S; Mitchell LA; Tingle AJ
    Vaccine; 1997; 15(6-7):648-52. PubMed ID: 9178465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A L.E.A.P.S. heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection.
    Goel N; Rong Q; Zimmerman D; Rosenthal KS
    Vaccine; 2003 Oct; 21(27-30):4410-20. PubMed ID: 14505924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Human CD4
    de Wit J; Emmelot ME; Poelen MCM; Lanfermeijer J; Han WGH; van Els CACM; Kaaijk P
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction and validation of potent peptides against herpes simplex virus type 1 via immunoinformatic and systems biology approach.
    Mehmood A; Kaushik AC; Wei DQ
    Chem Biol Drug Des; 2019 Sep; 94(5):1868-1883. PubMed ID: 31437863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53.
    Rojas JM; McArdle SE; Horton RB; Bell M; Mian S; Li G; Ali SA; Rees RC
    Cancer Immunol Immunother; 2005 Mar; 54(3):243-53. PubMed ID: 15449037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy.
    Liu K; Jiang D; Zhang L; Yao Z; Chen Z; Yu S; Wang X
    Vaccine; 2012 Apr; 30(19):3034-41. PubMed ID: 22008818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stepwise identification of HLA-A*0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus type 1 genome boosted by a StepRank scheme.
    Bi J; Song R; Yang H; Li B; Fan J; Liu Z; Long C
    Biopolymers; 2011; 96(3):328-39. PubMed ID: 21072852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD.
    Baghian A; Chouljenko VN; D'Auvergne O; Newman MJ; Baghian S; Kousoulas KG
    J Med Microbiol; 2002 Apr; 51(4):350-357. PubMed ID: 11926742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
    Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
    Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection.
    Nass PH; Elkins KL; Weir JP
    Vaccine; 2001 Jan; 19(11-12):1538-46. PubMed ID: 11163680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.